Sun Pharmaceutical Industries Ltd. benchmarking: Performance to industry peers

Financial

	Sun Pharma Inds.	Torrent Pharma	Lupin
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	665.0 .	172.0 .	431.0 .
Number of ANDA's Approved By USFDA	548.0 .	132.0 .	341.0 .
Domestic Sales Growth - YoY	15.2 %	17.2 %	12.8 %
US DMF Filings	532.0 .	n/a	93.0 .
US DMF Approval	402.0 .	n/a	n/a
R&D as a % of Total Sales	5.4 %	5.0 %	7.5 %
Financials
5 yr Average ROE	11.67 %	20.79 %	8.95 %
5yr average Equity Multiplier	1.33	2.16	1.73
5yr Average Asset Turnover Ratio	0.57	0.69	0.75
5yr Avg Net Profit Margin	15.4 %	13.95 %	5.06 %
Price to Book	5.22	15.98	5.3
P/E	37.25	59.42	22.41
5yr Avg Cash Conversion Cycle	-46.88 Days	-186.79 Days	-84.38 Days
Inventory Days	65.22 Days	54.98 Days	53.29 Days
Days Receivable	84.33 Days	40.18 Days	50.0 Days
Days Payable	175.41 Days	298.32 Days	160.27 Days
5yr Average Interest Coverage Ratio	44.12	7.38	6.26
5yr Avg ROCE	18.0 %	25.78 %	10.02 %
5yr Avg Operating Profit Margin	26.44 %	30.49 %	14.15 %
5 yr average Debt to Equity	0.06	0.66	0.3
5yr CAGR Net Profit	30.35 %	8.83 %	21.95 %
5yr Average Return on Assets	8.92 %	9.73 %	3.91 %
Shareholdings
Promoter Holding	54.48 %	68.31 %	46.89 %
Share Pledged by Promoters	0.97 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-2.94 %	-0.21 %
Change in Mutual Fund Holding (3 Yrs)	-0.37 %	-1.4 %	1.54 %

Business

	Sun Pharma Inds.	Torrent Pharma	Lupin
Product Wise Break-Up	Product Wise Break-Up India Branded Generics 33.0 US Formulations 30.0 Emerging Market 20.0 Western Europe & Other Markets 14.0 Active Pharmaceutical Ingredient (API) 3.0 Domestic formulations 0 Contract Manf. 0 Brazil/Latam 0 Germany/Europe 0 USA 0 Developed Markets 0 NCE licensing income 0 API 0 India 0 Emerging Market Formulation 0 Advanced Markets Formulations 0 Generic FDF 0 Custom Synthesis 0	Product Wise Break-Up API 0 India 0 USA 0 Brazil 8.98 Advanced Markets Formulations 0 Emerging Market 0 Contract Manufacturing 6.15 Germany 13.15 Generic FDF 0 Custom Synthesis 0 Domestic Formulations 42.15 US Formulations 20.71 Active Pharmaceutical Ingredient (API) 0 Developed Markets 0 Emerging Market Formulation 0 India Branded Generics 0 Western Europe & Other Markets 0 NCE licensing income 0 Others 8.86	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 9.0 India 34.0 USA 0 Brazil/Latam 0 Advanced Markets Formulations 45.0 Emerging Market 0 Contract Manf. 0 Germany/Europe 0 Generic FDF 0 Custom Synthesis 0 Domestic formulations 0 US Formulations 0 Active Pharmaceutical Ingredient (API) 0 Developed Markets 0 Emerging Market 12.0 India Branded Generics 0 Western Europe & Other Markets 0 NCD 1.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 19.0 Cardiac Science 17.0 Gastro Intestinal 14.0 Anti - Diabetes 9.0 Pain Management 7.0 Anti-Infective 6.0 Respiratory Systems 5.0 Vitamins / Minerals / Nutrients 5.0 Gynecology 4.0 Dermatology 4.0 Ophthalmology 3.0 Urology 3.0 Anti-Diabetes 0 Cardiac 0 Pain 0 Anti-Tuberculosis 0 Central Nervous System 0 Vitamins,Minerals,Supplements 0 Gastro intestinal 0 Anti-Infective 0 Others 4.0	-	Therapeutic Area Wise Break-Up - Domestic Vitamins / Minerals / Nutrients 3.0 Gastro Intestinal 10.0 Cardiac Science 23.0 Respiratory Systems 0 Anti - Diabetes 21.0 Pain Management 0 Anti-Tuberculosis 3.0 Ophthalmology 0 Cardiac Science 0 Dermatology 0 Central Nervous System (CNS) 0 Vitamins / Minerals / Nutrients 0 Central Nervous System (CNS) 5.0 Anti - Diabetes 0 Anti-Infective 7.0 Pain Management 3.0 Urology 0 Gastro Intestinal 0 Gynecology 0 Others 25.0
Location Wise Break-Up	Location Wise Break-Up India 33.39 USA 32.68 Emerging Market 19.13 Rest of the World 14.8 Germany 0 Brazil 0 API 0 EMEA 0 Growth Markets 0 Japan 0	Location Wise Break-Up API 0 India 54.44 USA 9.72 Growth Markets 0 Emerging Market 0 Rest of the World 0 Brazil 11.23 Japan 0 Germany 9.2 EMEA 0 Others 15.41	Location Wise Break-Up API 3.0 India 29.0 USA 44.0 Developed Markets 11.0 Emerging Market 0 Rest of the World 0 Brazil 0 Japan 0 Germany 0 EMEA 13.0

Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Ltd.

Financial

Business

SIGN UP FOR FREE